Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Anthera Pharmaceuticals Inc | 1,300,000 | reported | 17 May 2013 | tx 32+1,969,581−305,551 |
| Quince Therapeutics, Inc. | 265,000 | reported | 03 Mar 2022 | tx 29+806,963−183,926 |
| LifeSci Acquisition Corp. | 40,000 | reported | 25 Aug 2022 | tx 7+81,667 |
| HANSEN MEDICAL INC | 0 | reported | 27 Jul 2016 | tx 17+602,500−204,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Aug 2022 | PURCHASE | LifeSci Acquisition Corp. | 18,400 | 1.65 USD | first after silence |
| 25 Aug 2022 | PURCHASE | LifeSci Acquisition Corp. | 11,600 | 1.65 USD | |
| 26 May 2022 | GRANT_AWARD | LifeSci Acquisition Corp. | 15,000 | 0.00 USD | deriv |
| 03 Mar 2022 | GRANT_AWARD | Quince Therapeutics, Inc. | 175,000 | 0.00 USD | |
| 03 Jan 2022 | GRANT_AWARD | Quince Therapeutics, Inc. | 125,000 | 0.00 USD | deriv |
| 16 Nov 2021 | EXERCISE | Quince Therapeutics, Inc. | 30,000 | 2.23 USD | |
| 16 Nov 2021 | EXERCISE | Quince Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 05 Oct 2021 | SALE | Quince Therapeutics, Inc. | 4,963 | 98.50 USD | |
| 05 Oct 2021 | EXERCISE | Quince Therapeutics, Inc. | 4,963 | 54.85 USD | |
| 05 Oct 2021 | EXERCISE | Quince Therapeutics, Inc. | 4,963 | 0.00 USD | deriv |
| 16 Aug 2021 | SALE | Quince Therapeutics, Inc. | 1,100 | 97.28 USD | |
| 16 Aug 2021 | SALE | Quince Therapeutics, Inc. | 2,077 | 98.90 USD | |
| 17 Aug 2021 | EXERCISE | Quince Therapeutics, Inc. | 30,000 | 2.23 USD | |
| 16 Aug 2021 | SALE | Quince Therapeutics, Inc. | 7,335 | 95.02 USD | |
| 16 Aug 2021 | SALE | Quince Therapeutics, Inc. | 9,158 | 94.23 USD | |
| 16 Aug 2021 | EXERCISE | Quince Therapeutics, Inc. | 22,000 | 2.23 USD | |
| 16 Aug 2021 | SALE | Quince Therapeutics, Inc. | 2,330 | 96.32 USD | |
| 16 Aug 2021 | EXERCISE | Quince Therapeutics, Inc. | 22,000 | 0.00 USD | deriv |
| 17 Aug 2021 | EXERCISE | Quince Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 29 Jun 2021 | PURCHASE | LifeSci Acquisition Corp. | 6,400 | 12.59 USD | first after silence |
| 30 Jun 2021 | PURCHASE | LifeSci Acquisition Corp. | 3,600 | 12.66 USD | |
| 28 Jun 2021 | EXERCISE | Quince Therapeutics, Inc. | 20,000 | 2.23 USD | |
| 28 Jun 2021 | SALE | Quince Therapeutics, Inc. | 7,724 | 53.39 USD | |
| 28 Jun 2021 | SALE | Quince Therapeutics, Inc. | 7,079 | 54.13 USD | |
| 28 Jun 2021 | SALE | Quince Therapeutics, Inc. | 4,153 | 55.11 USD |
4 purchases reported after at least 12 months of silence — most recent on 24 Aug 2022.